Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutationsC Couture, A Saveanu, A Barlier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretionW Arlt, F Callies, I Koehler, et al.
Psychological Assessment|April 20, 2011
Assessing the forms and functions of aggression using self-report: factor structure and invariance of the Peer Conflict Scale in youthsMonica A Marsee, Christopher T Barry, Kristina K Childs, et al.
European Journal of Endocrinology|March 18, 2009
Merits and pitfalls of mifepristone in Cushing's syndromeF Castinetti, M Fassnacht, S Johanssen, et al.
International Journal of Cardiology|November 14, 2018
Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort studyCaroline Morbach, Götz Gelbrich, Theresa Tiffe, et al.
European Journal of Endocrinology|May 25, 2013
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resectionM Terzolo, A E Baudin, A Ardito, et al.
ESMO Open|February 6, 2026
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinomaB Altieri, S Kircher, S Herterich, et al.
Endocrine-Related Cancer|July 16, 2020
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation studyS G Creemers, R A Feelders, N Valdes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) studyR Libé, I Borget, C L Ronchi, et al.
Pageof 6